Update: Response Genetics Announces Novel Lung Cancer Testing Approach - Bull Thesis Strengthened
Christopher F. Davis • Yesterday, 9:51 AM
- Response Genetics it has launched a new and innovative Non-Small Cell Lung Cancer Profile that merges rapid turnaround on National Comprehensive Cancer Network guideline markers with next-generation sequencing.
- When I covered the company in depth I had discussed that novel tests in the pipeline were being developed and could serve as a catalyst for the company.
- The present news strengthens my bull thesis.